<div id="readability-page-1"><p>Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) have received an average recommendation of &#34;Moderate Buy&#34; from the six research firms that are  covering the firm, MarketBeat Ratings reports. One research analyst  has rated the stock with a sell rating, one  has issued  a hold rating, three have issued  a buy rating and one  has assigned  a strong buy rating to  the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $18.3750.</p><p>Several equities research analysts have recently weighed in on SENS shares. Weiss Ratings started coverage on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, February 17th. They issued a &#34;sell (d-)&#34; rating for the company. Stifel Nicolaus  set a $9.00 price objective on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, March 3rd. Finally, TD Cowen  reissued a &#34;buy&#34; rating on shares of Senseonics Holdings, Inc. Common Stock in a report on Thursday, January 8th.</p><p><b>View Our Latest Analysis on SENS</b></p><h2>Insider Activity at Senseonics Holdings, Inc. Common Stock</h2><p>In other news, CEO Timothy T. Goodnow acquired 17,225 shares of the firm's stock in a transaction dated Friday, March 13th. The stock was acquired at an average cost of $5.79 per share, with a total value of $99,732.75. Following the completion of the acquisition, the chief executive officer owned 651,243 shares of the company's stock, valued at $3,770,696.97. The trade was a 2.72% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Also, Director Douglas A. Roeder acquired 17,500 shares of the firm's stock in a transaction dated Friday, March 13th. The stock was purchased at an average cost of $5.73 per share, with a total value of $100,275.00. Following the completion of the acquisition, the director directly owned 119,731 shares of the company's stock, valued at approximately $686,058.63. This trade represents a 17.12% increase in their position. The SEC filing for this purchase provides additional information. 4.70% of the stock is currently owned by corporate insiders. </p><h2>Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock</h2><p>Several large investors have recently modified their holdings of the company. First Light Asset Management LLC boosted its holdings in shares of  Senseonics Holdings, Inc. Common Stock by 666.7% in the second quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company's stock valued at $17,011,000 after acquiring an additional 31,050,619 shares during the period.  Vanguard Group Inc. raised its stake in shares of  Senseonics Holdings, Inc. Common Stock by 2.2% during the third quarter. Vanguard Group Inc. now owns 34,219,484 shares of the company's stock worth $14,920,000 after purchasing an additional 749,453 shares during the last quarter.  Geode Capital Management LLC raised its stake in shares of  Senseonics Holdings, Inc. Common Stock by 26.6% during the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company's stock worth $4,147,000 after purchasing an additional 1,828,302 shares during the last quarter.  Masters Capital Management LLC raised its stake in shares of  Senseonics Holdings, Inc. Common Stock by 11.1% during the third quarter. Masters Capital Management LLC now owns 5,000,000 shares of the company's stock worth $2,179,000 after purchasing an additional 500,000 shares during the last quarter.  Finally, UBS Group AG raised its stake in shares of  Senseonics Holdings, Inc. Common Stock by 409.0% during the third quarter. UBS Group AG now owns 4,248,519 shares of the company's stock worth $1,852,000 after purchasing an additional 3,413,866 shares during the last quarter. 12.36% of the stock is owned by institutional investors and hedge funds. </p><h2>Senseonics Holdings, Inc. Common Stock Price Performance</h2><p>Shares of SENS opened at $5.10 on Monday. The company has a 50 day simple moving average of $6.82. The company has a debt-to-equity ratio of 0.58, a current ratio of 4.83 and a quick ratio of 4.55. The firm has a market capitalization of $213.13 million, a P/E ratio of -3.02 and a beta of 1.05. Senseonics Holdings, Inc. Common Stock has a 52-week low of $4.96 and a 52-week high of $15.20. </p><h2>About Senseonics Holdings, Inc. Common Stock</h2> (Get Free Report)<p>Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter. </p><p>Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.</p><h2>See Also</h2><ul><li>Five stocks we like better than Senseonics Holdings, Inc. Common Stock</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0VOUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0VOUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Senseonics Holdings, Inc. Common Stock Right Now?</h2><p>Before you consider Senseonics Holdings, Inc. Common Stock, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Senseonics Holdings, Inc. Common Stock wasn't on the list.</p><p>While Senseonics Holdings, Inc. Common Stock currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SENS

LABU

SBIO

<p>Senseonics Holdings, Inc. (NASDAQ:SENS) has received an average recommendation of "Moderate Buy" from six research firms. The stock has one sell, one hold, three buy, and one strong buy rating. The average target price is $18.3750. Recent insider transactions include CEO Timothy T. Goodnow acquiring 17,225 shares and Director Douglas A. Roeder acquiring 17,500 shares. Institutional investors have also increased their stakes significantly. The stock opened at $5.10, with a market cap of $213.13 million and a 52-week range of $4.96 to $15.20.</p>

Market Beat

Senseonics

Direxion S&P Biotech Bull 3X

SPDR S&P Biotech

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

Stifel Financial

Toronto Dominion Bank

UBS Group AG

STIFEL FINANCIAL CORP 6.125% DEP SHS REP 1/1000 NON CU PF SR C

Stifel Financial Pref Share SFB 5.2 10/15/47

STIFEL FINANCIAL CORP 6.25%NON CUM DEP SHS REP 1/1000TH SER B

STIFEL FINANCIAL CORP 4.50% DEP SHS REP 1/1000TH PREF SHS SR D

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Average Recommendation of "Moderate Buy" by Brokerages